Description

Lazolvan Solution for Inhalation 15 mg/2 ml. 100 ml

Ingredients:

Lazolvan solution for inhalation contains 15 mg of the active ingredient ambroxol hydrochloride per 2 ml.

Dosage:

For adults and children over 12 years old, the usual dose is 2-3 ml of Lazolvan solution for inhalation, 1-2 times a day.

Indications:

Lazolvan solution for inhalation is indicated for the treatment of respiratory conditions associated with viscid mucus, such as acute and chronic bronchitis, bronchiectasis, and other conditions that require enhanced mucus clearance.

Contraindications:

Do not use Lazolvan solution for inhalation if you are allergic to ambroxol or any other ingredients in the product.

Directions:

For inhalation use only. Dilute the solution with normal saline solution before use. Use a nebulizer to inhale the medication. Follow the instructions provided by your healthcare provider.

Scientific Evidence:

Studies have shown that ambroxol, the active ingredient in Lazolvan solution for inhalation, has mucolytic and expectorant properties, helping to reduce the viscosity of mucus in the respiratory tract and improve mucus clearance. This can lead to improved lung function and symptom relief in respiratory conditions.

Additional Information:

It is important to note that Lazolvan solution for inhalation should not be used without medical supervision, especially in patients with a history of respiratory conditions or allergies. Always consult a healthcare professional before starting any new medication.

Furthermore, clinical trials have demonstrated the efficacy of ambroxol in improving lung function and reducing symptoms in patients with acute and chronic respiratory conditions. The use of mucolytic agents like ambroxol can play a significant role in the management of respiratory diseases.